 PLYMOUTH MEETING, Pa., March 9, 2022 PRNewswire -- Harmony Biosciences Holdings, Inc. Harmony or the Company Nasdaq: HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that its executive leaders will participate in the following upcoming virtual conferences: Oppenheimer 32nd Annual Healthcare Conference Fireside Chat: Tuesday, March 15; 2:40 p.m. 